Invention Publication
- Patent Title: LIQUID DALBAVANCIN COMPOSITIONS
-
Application No.: US18484819Application Date: 2023-10-11
-
Publication No.: US20240139282A1Publication Date: 2024-05-02
- Inventor: Martina Manenica , Ema Kovacevic , Ernest Mestrovic
- Applicant: Xellia Pharmaceuticals ApS
- Applicant Address: DK Copenhagen
- Assignee: Xellia Pharmaceuticals ApS
- Current Assignee: Xellia Pharmaceuticals ApS
- Current Assignee Address: DK Copenhagen
- Priority: DK 202200932 2022.10.12 EP 157323.9 2023.02.17
- Main IPC: A61K38/14
- IPC: A61K38/14 ; A61K9/08 ; A61K47/26 ; A61K47/40
Abstract:
The present disclosure relates to a stable aqueous composition of dalbavancin, the process for making such compositions and use of such compositions for treatment of a patient in need thereof.
Public/Granted literature
- US12070485B2 Liquid dalbavancin compositions Public/Granted day:2024-08-27
Information query
IPC分类:
